Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biomed Lublin Wytwornia Surowic i Szczepionek SA
WSE:BML
|
PL |
|
Vaxcyte Inc
NASDAQ:PCVX
|
US |
|
I
|
Impresa Sociedade Gestora de Participacoes Sociais SA
ELI:IPR
|
PT |
|
Baselode Energy Corp
XTSX:FIND
|
CA |
|
Apyx Medical Corp
NASDAQ:APYX
|
US |
|
T
|
Trencor Ltd
JSE:TRE
|
ZA |
|
Showa Sangyo Co Ltd
TSE:2004
|
JP |
Intrinsic Value
The intrinsic value for Biomed Lublin Wytwornia Surowic i Szczepionek SA (BML) under the Base Case is hidden PLN. Compared with the current market price of 5.8 PLN, the stock appears hidden .
Do our valuations actually work? See backtest results .
BML looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether BML usually does or if today's premium is unusual.
See where today’s valuation sits in BML’s own history and what typically happened over the next 12 months after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Biomed Lublin Wytwornia Surowic i Szczepionek SA.
Fundamental Analysis
Revenue & Expenses Breakdown
Biomed Lublin Wytwornia Surowic i Szczepionek SA
Earnings Waterfall
Biomed Lublin Wytwornia Surowic i Szczepionek SA
The intrinsic value for Biomed Lublin Wytwornia Surowic i Szczepionek SA (BML) under the Base Case is hidden PLN.
Compared with the current market price of 5.8 PLN, the stock appears hidden.